Team
The RYSE team consists of experienced clinicians, researchers, and entrepreneurs who come together to drive innovation in healthcare.
Shabir Chowdhary
Founding Partner
Finance & Structuring
Investor, biochemist, and former banker at Merrill Lynch, Morgan Stanley & Schroders. Experience in investing in and scaling companies across multiple sectors, raising more than $4.5B in aggregate and exiting to strategic buyers across the globe.
Dr John Lee Allen
Partner
Healthcare
Physician, scientist, engineer, founder, and investor experienced in driving innovation globally and securing millions in investment. Cambridge University Fellow and NHS Board member, with pivotal innovation leadership roles at Harvard, Johns Hopkins, Specsavers, and the WHO.
Vivien de Tusch-Lec
General Partner
Strategy & Growth
Founder and technology operator with three successful startup exits. Investor and former journalist graduating from Cambridge and INSEAD. Non-Executive Director at Techspert.io and previously built the Tech, Media, Telecom unit for B2B Marketplace at Gerson Lehman Group.
David Seemungal
Partner
Partnerships & Distribution
Healthcare investor with over 25 years of experience in policy and distribution contracts. Previously served as Head of Pharma & Biotech Equity Research at ING’s investment banking division, Deputy Head at S&P Global Equity Research, and Senior Policy Advisor at the Welcome Trust.
The team is supported by a large team of global scientific and commercial HealthTech experts.
Dr Laila Samady-Mustad
Venture Partner
Senior scientist, business development executive, and investor with over 25 years’ experience in R&D, Medical Affairs, Pharma Partnerships, MedTech and Biotech in Europe and the US. Her PhD work at UCL led to the creation of a spinout company, BioVex (acquired by Amgen for $1B).
Everett Kamin
Board Advisor
Seasoned finance professional with investment banking, private equity and venture capital experience across 100+ transactions totalling over $50B. MBA from Warwick Business School and Fintech Wharton Executive Education. Over 24 years’ experience across Healthcare, Retail, Logistics, Staffing, Automotive and Tech.
Kevin Roberts
Leadership
Ex-CEO Worldwide and Chairman at Saatchi & Saatchi and world-class creative leader who helps founders commercialise products. Has previously built recognisable global brands for P&G, Toyota, Walmart, Novartis, Boston Scientific, and J&J globally.
Dr Annalisa Jenkins
Chair
Senior healthcare executive, investor, and key opinion leader who has built R&D teams and launched multi-billion dollar drugs globally. She is a member of the board at Science Advisory Board at the FDA, Milken Institute FasterCures, and Genomics England.
Dr Benjamin Maddison
Venture Advisor
PHD scientist with a passion for creating tomorrow through scalable, sustainable innovation and business transformation. Experienced working with some of the largest global consumer brands for Costa Coffee and Unilever.
Fergus Hay
Board Advisor
Technology and media leader with a track record in commercial transformation, product innovation and growth. Regular commentator on global tech news for Sky, NBC, and the BBC. Previously served on the annual fundraising committee of the British Heart Foundation.
Dr David Holbrook
Venture Advisor
Senior venture capitalist leader in UK university technology spinouts for over 20 years (led ApaTech that sold to Baxter for $300M). Previously served as BD physician at GSK and Roche and lead Imperial’s incubator, MTI’s MedTech investments, and LifeArc's Seed Fund
Dr Aleksandar Petrović
Venture Advisor
Healthcare leader with significant expertise in life sciences spanning strategy, consulting (IQVIA), entrepreneurial market expansion (Sensirion), and digital innovation (Siemens).